Skip to content

The effect of Selenium on Idiopathic Tinnitus

Clinical trial of the effect of selenium in idiopathic tinnitus

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160813029327N24
Enrollment
60
Registered
2024-09-20
Start date
2024-09-22
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinnitus. Tinnitus

Interventions

Intervention 1: Intervention group: For people who met the criteria for entering the research, they will receive a Selenium supplement in the form of 200 microgram tablet every day for two months - Se

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Having tinnitus that does not have specific pathological examinations. Having normal hearing or Suffering from degrees of mild to severe hearing loss in the frequency range of 250-8000 Hz

Exclusion criteria

Exclusion criteria: Taking anticoagulant drugs Pregnancy or intention to become pregnant Not being in a good general mood Observing any unforeseen complications Lack of cooperation in psychoacoustic assessments of tinnitus Receiving concomitant medical treatment or other tinnitus rehabilitation History of Otological and Neurological Diseases Breastfeeding Presence of pulsating tinnitus

Design outcomes

Primary

MeasureTime frame
Tinnitus annoyance index. Timepoint: At the beginning of the study (before the intervention) and 60 days after starting the treatment. Method of measurement: Tinnitus Handicap Inventory (THI) questionnaire.

Secondary

MeasureTime frame
Psychoacoustic assessments of tinnitus. Timepoint: At the beginning of the study (before the intervention) and 60 days after starting the treatment. Method of measurement: Determination of perceived loudness of tinnitus by the patient through LMT(Loudness Matching of Tinnitus), PMT(Pitch Matching of Tinnitus), MML(Minimal Masking Level).;Hearing threshold. Timepoint: At the beginning of the study (before the intervention) and 60 days after starting the treatment. Method of measurement: Audiogram chart or ear tape.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactYounes Lotfi

Shahid Beheshti University of Medical Sciences

yones1333@gmail.com+98 21 2220 5326

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026